About Pediococcus Acidilactici
Pediococcus Acidilactici is a company based in Panchkula (India) founded in 2022. It operates as a B2B. Pediococcus Acidilactici offers products and services including Pediococcus Acidilactici, Enzymes, Probiotics Blends, and Nutraceuticals. Pediococcus Acidilactici operates in a competitive market with competitors including Wacker Chemie, AMILI, Enduro, BioCina and BDI biotech, among others.
- Headquarter Panchkula, India
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Fido Pharma Private Limited
- Date of Incorporation 04 Mar, 2020
- Jurisdiction Panchkula, Haryana, India
-
Annual Revenue
$2.41 M (USD)189.93as on Mar 31, 2024
-
Net Profit
$475.76 K (USD)790.75as on Mar 31, 2024
-
EBITDA
$571.37 K (USD)410.14as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pediococcus Acidilactici
Pediococcus Acidilactici offers a comprehensive portfolio of products and services, including Pediococcus Acidilactici, Enzymes, Probiotics Blends, and Nutraceuticals.
Probiotic strain offering antibacterial activity against pathogens in GI tract.
Solutions for industrial applications in health and food processing.
Blends for dietary supplements and health benefits.
Formulations supporting health in cosmetics and food industries.
Funding Insights of Pediococcus Acidilactici
Detailed funding history for Pediococcus Acidilactici
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pediococcus Acidilactici
Investment portfolio details for Pediococcus Acidilactici
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pediococcus Acidilactici
Detailed financials for Pediococcus Acidilactici
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pediococcus Acidilactici Comparisons
Peer comparison for Pediococcus Acidilactici
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pediococcus Acidilactici
Pediococcus Acidilactici operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wacker Chemie, AMILI, Enduro, BioCina and BDI biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Silicones, polymers, and bio-solutions are manufactured for various industries.
|
|
| Locked | Locked | Locked |
Gut microbiome insights, analytics, tests, and therapeutics are provided.
|
|
| Locked | Locked | Locked |
Microbial strains are manufactured by Enduro as a CDMO.
|
|
| Locked | Locked | Locked |
CDMO offering microbial expression systems-based biologics development and manufacturing services
|
|
| Locked | Locked | Locked |
Microbial strains for biopharma are developed at BDI Biotech.
|
|
| Locked | Locked | Locked |
CDMO offering development, cGMP manufacturing and fill/finish of biologics based on viruses and bacteria
|
Detailed competitors of Pediococcus Acidilactici
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pediococcus Acidilactici
Complete news archive for Pediococcus Acidilactici
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pediococcus Acidilactici
Pediococcus Acidilactici was founded in 2022.
Pediococcus Acidilactici is headquartered in Panchkula, India. It is registered at Panchkula, Haryana, India.
Annual revenue of Pediococcus Acidilactici is $2.41M as on Mar 31, 2024.
Fido Pharma Private Limited delivers enzyme solutions and probiotics for industries including biopharmaceutical, fine chemicals, food and feed, and cosmetics. They produce products like Pediococcus Acidilactici, a probiotic strain with antibacterial properties for gastrointestinal health. Based in India with facilities in Panchkula and Hyderabad, the company focuses on manufacturing high-quality formulations for industrial applications, serving clients in health and related sectors through direct supply chains.
Pediococcus Acidilactici's top competitors include Wacker Chemie, AMILI and Enduro.
Pediococcus Acidilactici offers Pediococcus Acidilactici, Enzymes, Probiotics Blends, and Nutraceuticals.